EN 日本語 Search Investors Investigators Contact Us Services Therapeutics Innovation Insights News & Events About Careers 1 2 3 Welcome to ICON ICON is a global provider of outsourced drug development services to biopharma, medical device, government, biosimilar and generic organisations. We offer a full range of clinical, consulting and commercial services that range from trial design to full study execution, and from clinical to post-market commercialisation. Our services are supported by in-depth therapeutic and regulatory expertise and market-leading technology and analytics. We are the only full service CRO that offers the knowledge, software and systems for adaptive trials. Immuno-oncology White Paper Developing Immuno-oncology trials requires thoughtful planning. Download ICON’s latest white paper. ICON Insights Regenerative Medicine Advanced Therapy Designation - Supporting Expedition in Drug Development » Immuno-oncology: Am I choosing the right biomarker? » Future of Bioanalytical Laboratories » Wearables Address the complexities of implementation of wearable devices in trial design, execution and reporting. Linking Evidence and Value Strategies with the Right Stakeholder Webinar: 13 October, 2017 learn about integrating evidence development and market access processes to target the same value proposition stakeholders. Social Media CONTACT ABOUT ICON RESULTS & REPORTS for Clients Therapeutics Services Insights Innovation ICON for Investigators Media Volunteers Investors Jobs & Careers News & Events Press Releases Events ICON on Social Media © 2017 ICON plc. Sitemap Disclaimer Privacy LinkedIn Twitter Facebook Youtube